ArticleInternational immunopharmacology2021

Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study.

Suzan M Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.